Yuchun Lee - Apr 8, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Apr 8, 2022
Transactions value $
-$791,580
Form type
4
Date filed
4/12/2022, 04:07 PM
Previous filing
Apr 8, 2022
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $163K +2K +106.67% $81.54 3.88K Apr 8, 2022 Direct
transaction VRTX Common Stock Sale -$116K -418 -10.79% $276.62 3.46K Apr 8, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$119K -430 -12.44% $277.29 3.03K Apr 8, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$196K -700 -23.13% $279.36 2.33K Apr 8, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$127K -452 -19.42% $280.37 1.88K Apr 8, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Options Exercise $163K +2K +106.67% $81.54 3.88K Apr 11, 2022 Direct
transaction VRTX Common Stock Sale -$258K -922 -23.79% $279.81 2.95K Apr 11, 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$272K -968 -32.78% $280.62 1.99K Apr 11, 2022 Direct F1, F2, F8
transaction VRTX Common Stock Sale -$31K -110 -5.54% $281.58 1.88K Apr 11, 2022 Direct F1, F2, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2K -16.67% $0.00 10K Apr 8, 2022 Common Stock 2K $81.54 Direct F10
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2K -20% $0.00 8K Apr 11, 2022 Common Stock 2K $81.54 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81).
F4 Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46).
F5 Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74).
F6 Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02).
F7 Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18).
F8 Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28).
F9 Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58).
F10 Fully vested.